DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
ACHN-975
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ACHN-975
×
Maximum Phase:
1
First Approval:
None
UNII:
48CET2EN53
Molecule Type:
Small molecule
Molecular Formula:
C20H23N3O4
Molecular Weight:
369.42
AlogP:
0.01
PSA:
124.68
HBD:
5.0
HBA:
#RotB:
5.0
Source:
GLPG0492
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Androgen Receptor modulator
GLPG0492
×
Maximum Phase:
1
First Approval:
None
UNII:
8O59X1ACZT
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MMV-390048
1
Small molecule
Investigational
Unknown
Unknown
Malaria; Malaria, Falciparum
Unknown
MMV-390048
×
Maximum Phase:
1
First Approval:
None
UNII:
0Z5T00JJ10
Molecule Type:
Small molecule
Molecular Formula:
C18H14F3N3O2S
Molecular Weight:
393.39
AlogP:
3.82
PSA:
85.94
HBD:
1.0
HBA:
#RotB:
3.0
Source:
FACTOR IX COMPLEX
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
FACTOR IX COMPLEX
×
Maximum Phase:
1
First Approval:
None
UNII:
FW411QXD5M
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MUPLESTIM
1
Protein
Investigational
Unknown
Unknown
HIV Infections
Unknown
MUPLESTIM
×
Maximum Phase:
1
First Approval:
None
UNII:
A802907MI4
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FGF-1 141
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
FGF-1 141
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-06671008
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
PF-06671008
×
Maximum Phase:
1
First Approval:
None
UNII:
2GWZ8HN70W
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KETOPROFEN LYSINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
KETOPROFEN LYSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
5WD00E3D4C
Molecule Type:
Small molecule
Molecular Formula:
C22H28N2O5
Molecular Weight:
400.48
AlogP:
3.11
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
4.0
Source:
BORNEOL
1
Small molecule
Investigational
Unknown
Unknown
Angina, Stable
Unknown
BORNEOL
×
Maximum Phase:
1
First Approval:
None
UNII:
M89NIB437X
Molecule Type:
Small molecule
Molecular Formula:
C10H18O
Molecular Weight:
154.25
AlogP:
2.19
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
0.0
Source:
.ALPHA.-PYRROLIDINONONANOPHENONE
1
Small molecule
Investigational
Unknown
Unknown
Melanoma
Unknown
.ALPHA.-PYRROLIDINONONANOPHENONE
×
Maximum Phase:
1
First Approval:
None
UNII:
S3FKL8RY1D
Molecule Type:
Small molecule
Molecular Formula:
C19H29NO
Molecular Weight:
287.45
AlogP:
4.69
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
9.0
Source:
KB-004
1
Antibody
Investigational
Unknown
Unknown
Glioblastoma; Myelodysplastic Syndromes; Primary Myelofibrosis
Ephrin type-A receptor 3 inhibitor
KB-004
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EVEXOMOSTAT
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
EVEXOMOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MONEPANTEL
1
Small molecule
Investigational
Unknown
Unknown
Motor Neuron Disease
Unknown
MONEPANTEL
×
Maximum Phase:
1
First Approval:
None
UNII:
82MA79VJ33
Molecule Type:
Small molecule
Molecular Formula:
C20H13F6N3O2S
Molecular Weight:
473.4
AlogP:
5.28
PSA:
85.91
HBD:
1.0
HBA:
#RotB:
6.0
Source:
GSK-2239633
1
Small molecule
Investigational
Unknown
Unknown
Asthma
Unknown
GSK-2239633
×
Maximum Phase:
1
First Approval:
None
UNII:
07ODS257BP
Molecule Type:
Small molecule
Molecular Formula:
C21H19ClN4O5S2
Molecular Weight:
506.99
AlogP:
3.54
PSA:
122.55
HBD:
3.0
HBA:
#RotB:
8.0
Source:
MCAF5352A
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MCAF5352A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TUROFEXORATE ISOPROPYL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Bile acid receptor FXR agonist
TUROFEXORATE ISOPROPYL
×
Maximum Phase:
1
First Approval:
None
UNII:
S6KDM312I5
Molecule Type:
Small molecule
Molecular Formula:
C25H24F2N2O3
Molecular Weight:
438.47
AlogP:
5.17
PSA:
62.4
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ELTANEXOR
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ELTANEXOR
×
Maximum Phase:
1
First Approval:
None
UNII:
Q59IQJ9NTK
Molecule Type:
Small molecule
Molecular Formula:
C17H10F6N6O
Molecular Weight:
428.3
AlogP:
3.26
PSA:
99.58
HBD:
1.0
HBA:
#RotB:
4.0
Source:
RO-3201195
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
RO-3201195
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C19H18FN3O4
Molecular Weight:
371.37
AlogP:
1.56
PSA:
110.6
HBD:
3.0
HBA:
#RotB:
7.0
Source:
MSC-2364447
1
Small molecule
Investigational
Unknown
Unknown
Lupus Erythematosus, Systemic
Tyrosine-protein kinase BTK inhibitor
MSC-2364447
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SIMMITECAN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SIMMITECAN
×
Maximum Phase:
1
First Approval:
None
UNII:
T4H02O147G
Molecule Type:
Small molecule
Molecular Formula:
C34H38N4O6
Molecular Weight:
598.7
AlogP:
4.26
PSA:
114.2
HBD:
1.0
HBA:
#RotB:
5.0
Source:
LXI-15029
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LXI-15029
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BARDOXOLONE
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma
Unknown
BARDOXOLONE
×
Maximum Phase:
1
First Approval:
None
UNII:
7HT68L8941
Molecule Type:
Small molecule
Molecular Formula:
C31H41NO4
Molecular Weight:
491.67
AlogP:
6.29
PSA:
95.23
HBD:
1.0
HBA:
#RotB:
1.0
Source:
NT-219
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NT-219
×
Maximum Phase:
1
First Approval:
None
UNII:
K1WT1A1UP5
Molecule Type:
Small molecule
Molecular Formula:
C16H14BrNO5S
Molecular Weight:
412.26
AlogP:
3.11
PSA:
113.18
HBD:
6.0
HBA:
#RotB:
4.0
Source:
CERGUTUZUMAB AMUNALEUKIN
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
CERGUTUZUMAB AMUNALEUKIN
×
Maximum Phase:
1
First Approval:
None
UNII:
48FCG62C25
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SB1578
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SB1578
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MLN-8054
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Colonic Neoplasms; Neoplasms; Pancreatic Neoplasms
Serine/threonine-protein kinase Aurora-A inhibitor
MLN-8054
×
Maximum Phase:
1
First Approval:
None
UNII:
BX854EHD63
Molecule Type:
Small molecule
Molecular Formula:
C25H15ClF2N4O2
Molecular Weight:
476.87
AlogP:
5.87
PSA:
87.47
HBD:
2.0
HBA:
#RotB:
4.0
Source:
MDX-1342
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell
B-lymphocyte antigen CD19 binding agent
MDX-1342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIO89-100
1
Unknown
Investigational
Unknown
Unknown
Hypertriglyceridemia; Non-alcoholic Fatty Liver Disease
Unknown
BIO89-100
×
Maximum Phase:
1
First Approval:
None
UNII:
UO870O6MFS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARD-024
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CARD-024
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NORBUPRENORPHINE
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
NORBUPRENORPHINE
×
Maximum Phase:
1
First Approval:
None
UNII:
7E53B4O073
Molecule Type:
Small molecule
Molecular Formula:
C25H35NO4
Molecular Weight:
413.56
AlogP:
3.29
PSA:
70.95
HBD:
3.0
HBA:
#RotB:
2.0
Source:
BALAFILCON A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BALAFILCON A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ERY974
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ERY974
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
UNESBULIN
1
Small molecule
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Leiomyosarcoma; Neoplasms; Ovarian Neoplasms
Unknown
UNESBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
Z4HZ70S62Q
Molecule Type:
Small molecule
Molecular Formula:
C19H13F5N6
Molecular Weight:
420.35
AlogP:
4.75
PSA:
81.65
HBD:
2.0
HBA:
#RotB:
3.0
Source:
SELITRECTINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Neurotrophic tyrosine kinase receptor inhibitor
SELITRECTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
0J45910S3X
Molecule Type:
Small molecule
Molecular Formula:
C20H21FN6O
Molecular Weight:
380.43
AlogP:
2.67
PSA:
75.42
HBD:
1.0
HBA:
#RotB:
0.0
Source:
CSL-360
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Interleukin-3 receptor subunit alpha inhibitor
CSL-360
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
91
92
93
94
95
96
97
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA